GERTHY MICHEL: Open Payments
NPI 1679120612 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,168 in 102 payments from 8 companies in 2025. Trend: 2023 $431 · 2024 $1,979 · 2025 $3,168
Food & beverage: $3,117Education: $51
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 50 | $1,731 |
| ABBVIE INC. | 18 | $509 |
| Takeda Pharmaceuticals U.S.A., Inc. | 17 | $409 |
| Lilly USA, LLC | 8 | $193 |
| AstraZeneca Pharmaceuticals LP | 1 | $120 |
| Aimmune Therapeutics, Inc. | 5 | $111 |
| QOL Medical, LLC | 2 | $70 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $25 |
Products named: TREMFYA, ENTYVIO, RINVOQ, OMVOH, WAINUA, SKYRIZI, VOWST, Sucraid.
Industry payments across NY — which companies pay providers there.
